Aminosalicylic Acid

Aminosalicylic Acid

SCHEMBL84166

Nc1ccc(C(=O)[O-])c(O)c1.O.O.[Na+]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folA

The experimentally established mechanism targets of Aminosalicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.96
TDP1 Q9NUW8 4/20 0.96
POLB P06746 2/20 0.96
ALDH1A1 P00352 6/20 0.62
MAPT P10636 5/20 0.62
CYP3A4 P08684 3/20 0.62
GAA P10253 2/20 0.62
ESR2 Q92731 1/20 0.62
PTPN1 P18031 1/20 0.62
HPGD P15428 2/20 0.50
KDR P35968 2/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
CHRM1 P11229 1/20 0.49
TBXA2R P21731 1/20 0.49
SLC6A2 P23975 1/20 0.49
PDE4A P27815 1/20 0.49
ADRA1A P35348 1/20 0.49
SLC6A3 Q01959 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aminosalicylic Acid SCHEMBL29425268 1.00 KDM4E (0.96) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL688206 0.98 KDM4E (1.00) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL29379024 0.98 KDM4E (1.00) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL11788856 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL1047421 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL1457932 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL1477512 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL31065282 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL31598403 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT
Aminosalicylic Acid SCHEMBL30724149 0.94 KDM4E (0.92) KDM4ETDP1POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10852 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-04-30 US claimed
US-12522572-B2 Isoxazole hydroxamic acids as histone deacetylase 6 inhibitors THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-01-13 US claimed
CN-118880486-B Cool polyester fiber and preparation method thereof 江苏恒科新材料有限公司 2025-06-24 CN claimed
US-12274830-B2 Nitric oxide inhalation therapy for infants with bronchiolitis BEYOND AIR LTD (IL) 2025-04-15 US claimed
CN-118880486-A Cool polyester fiber and preparation method thereof 江苏恒科新材料有限公司 2024-11-01 CN claimed
US-20240343697-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2024-10-17 US claimed
US-12045185-B2 Highly scalable accelerator INTEL CORPORATION (US) 2024-07-23 US claimed
US-12045640-B2 System, apparatus and method for accessing multiple address spaces via a data mover INTEL CORPORATION (US) 2024-07-23 US claimed
US-20240243913-A1 CUSTOMERS KEY PROTECTION FOR CLOUD NATIVE DEPLOYMENTS INTEL CORPORATION 2024-07-18 US claimed
US-12032491-B2 2024-07-09 US claimed
US-20040092583-A1 Treatment for inhibiting neoplastic lesions SHANAHAN-PRENDERGAST ELIZABETH (IE) 2004-05-13 US claimed
US-20040077601-A1 Methods and compositions relating to isoleucine boroproline compounds POINT THERAPEUTICS, INC. 2004-04-22 US claimed
WO-2004004658-A2 METHODS AND COMPOSITIONS RELATING TO ISOLEUCINE BOROPROLINE COMPOUNDS POINT THERAPEUTICS, INC. (US) 2004-01-15 WO claimed
EP-1351678-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS Shanahan-Prendergast, Elizabeth (IE) 2003-10-15 EP claimed
WO-2002053138-A2 TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS SHANAHAN-PRENDERGAST ELISABETH (IE) 2002-07-11 WO claimed
US-20020042394-A1 Cobalamin compounds useful as antibiotic agents and as imaging agents HOGENKAMP HENRICUS P C (US) 2002-04-11 US claimed
WO-2001092288-A2 COBALAMIN COMPOUNDS USEFUL AS ANTIBIOTIC AGENTS AND AS IMAGING AGENTS MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2001-12-06 WO claimed
US-6245735-B1 CONJUGATE OF ANTIBIOTIC AND POLYPEPTIDE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR OR LIPOPOLYSACCHARIDE BINDING FRAGMENT THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2001-06-12 US claimed
EP-0606361-A1 Rubber Composition HER MAJESTY THE QUEEN as represented by THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) 1994-07-20 EP claimed
WO-1993007211-A1 RUBBER ADDITIVE HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) 1993-04-15 WO claimed